A Study to Evaluate the Effect of KarXT on Urological Safety

Abroad (travel likely)RecruitingPHASE4

Conditions

Schizophrenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Pillar Clinical Research- Little Rock, Little Rock, Arkansas, United States

    Contact: Study coordinator (Leslie Smith) · 501-350-3285
  • Clinical Innovations, Inc. dba CITrials, Bellflower, California, United States

    Contact: Study coordinator (Robert Bota) · 562-748-4999
  • CenExel CNS - Garden Grove, Garden Grove, California, United States

    Contact: Study coordinator (David Walling) · 714-799-7799
  • ATP Clinical Research, Orange, California, United States

    Contact: Study coordinator (Gustavo Alva) · 949-354-5353
  • Innovative Clinical Research, Lauderhill, Florida, United States

    Contact: Study coordinator (Rishi Kakar) · 786-512-4106
  • Health Synergy Clinical Research, West Palm Beach, Florida, United States

    Contact: Study coordinator (Mohammad Nisar) · 786-831-7303
  • Uptown Research Institute, Chicago, Illinois, United States

    Contact: Study coordinator (John Sonnenberg) · 773-968-9868
  • Pillar Clinical Research -Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Roueen Rafeyan) · 312-865-6336
  • IMA Clinical Research Las Vegas, Las Vegas, Nevada, United States

    Contact: Study coordinator (Mustafa Rawaf) · 702-527-7401
  • Hassman Research Institute Marlton Site, Marlton, New Jersey, United States

    Contact: Study coordinator (Elan Cohen) · 267-981-8911
  • Adams Clinical Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Cassie Blanchard) · 631-252-0769
  • Local Institution - 0001, Austin, Texas, United States

  • InSite Clinical Research, DeSoto, Texas, United States

    Contact: Study coordinator (Benji Kurian) · 214-497-3151
Study leads
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb